1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trialinterstitial lung disease, lung disorder, respiratory system disorderRecruitingPhase 12025-04-10NCT06919380